![Arsène Guekam](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Arsène Guekam
Corporate Officer/Principal chez AELIS FARMA
Provenance du réseau au premier degré de Arsène Guekam
Entité | Type d'entité | Industrie | |
---|---|---|---|
Kepler Cheuvreux SA
![]() Kepler Cheuvreux SA Investment Banks/BrokersFinance Kepler Cheuvreux SA is an independent broker/dealer headquartered in Paris, France. The firm was founded by Laurent Quirin in 1997. Kepler Cheuvreux provides execution services to institutional investors. It supports equities, fixed income, derivatives, ETFS, and convertible bonds across Europe, America and Asia.
50
| Holding Company | Investment Banks/Brokers | 50 |
11
| Public Company | Biotechnology | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Arsène Guekam via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Alphavalue SA
![]() Alphavalue SA Investment ManagersFinance Alphavalue SA is an independent investment research firm headquartered in Paris, France. The firm was co-founded by Pierre-Yves Gauthier in 2007. The firm provides independent European equity and credit research, offers agnostic analysis of business models and valuations, and helping clients assess their investment risks and opportunities. They combine sustainability opinions with their fundamental financial analysis to produce integrated target prices. | Investment Managers | Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity | |
Natixis SA (Broker)
![]() Natixis SA (Broker) Investment Banks/BrokersFinance Natixis SA (Broker) is the securities brokerage division of Natixis SA (EPA: KN), a corporate and investment bank headquartered in Paris, France. They are ultimately owned by BCPE SA. The firm provides full spectrum of broking services to various investors. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity | |
Deutsche Bank AG (France) | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
Raymond James Euro Equities SAS
![]() Raymond James Euro Equities SAS Investment Banks/BrokersFinance Part of Raymond James Financial, Inc., Raymond James Euro Equities SAS is a brokerage services provider. The company is based in Paris, France. The French company was founded in 2001 by Philippe Andrieu, David Kruk, Laurent Thomasset. The CEO is Thierry Guille. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
Bryan, Garnier & Co Ltd. (France) | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Kepler Cheuvreux SA (Switzerland)
![]() Kepler Cheuvreux SA (Switzerland) Investment Banks/BrokersFinance Kepler Cheuvreux SA (Switzerland) (Kepler Cheuvreux Switzerland) is the Swiss broker/dealer division of Kepler Cheuvreux SA in France. The firm was founded in 1999 and is headquartered in Zurich. Kepler Cheuvreux Switzerland provides execution services platform that supports Equities, Fixed Income, Derivatives, ETFs, and Convertible Bonds. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
Theia Recherche
![]() Theia Recherche Investment ManagersFinance Theia Recherche is an independent investment research firm headquartered in Paris, France. The firm was founded by François Digard in 2021. They provide French small and mid-caps with useful financial analysis coverage for investors. Their analyses are based on an approach that combines financial and non-financial criteria from the outset in order to meet contemporary investor expectations. | Investment Managers | Founder | |
Global Antibiotic Research & Development Partnership
![]() Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics. | Biotechnology | Director/Board Member | |
Oddo BHF SCA (Broker)
![]() Oddo BHF SCA (Broker) Investment Banks/BrokersFinance Oddo BHF SCA (Broker) is the securities brokerage division of Oddo BHF SCA, a financial services company headquartered in Paris, France. The firm provides equity brokerage services to various investors. | Investment Banks/Brokers | Analyst-Equity | |
Société de Bourse Gilbert Dupont SNC
![]() Société de Bourse Gilbert Dupont SNC Investment Banks/BrokersFinance Société de Bourse Gilbert Dupont SNC is engaged in providing brokerage services in financial markets. The company was founded in 1992 and is headquartered in Paris, France. | Investment Banks/Brokers | Analyst-Equity | |
BDL Capital Management SAS
![]() BDL Capital Management SAS Investment ManagersFinance BDL Capital Management SAS (BDL) is an independent asset management firm headquartered in Paris, France. The firm was founded in 2005 by three founding partners wholly own the company. BDL manages savings for institutional clients (insurance companies, pension funds, mutual insurance companies, etc.), private banks and asset management consultants. | Investment Managers | Analyst-Equity | |
Ossiam SA
![]() Ossiam SA Investment ManagersFinance Ossiam SA (Ossiam) is the asset management subsidiary of Natixis Global Asset Management SA, wholly-owned by Natixis SA (XP: KN) and ultimately held by BPCE SA in France. Established in 2009, Ossiam is based in Paris and offers complementary and varied investment strategies that are easy to integrate into a global portfolio. Their range of specialty ETFs offers an alternative to traditional equity market cap-weighted indexes. The firm’s Scientific Council conducts research in mathematical finance and economics, meeting periodically with the Ossiam research and management team to examine the quantitative tools and models used at Ossiam and exchange on new themes of investment, quantitative management, new model applications and recent findings. | Investment Managers | Director of Research - Equity | |
Georgetown University Law Center | College/University | Corporate Officer/Principal | |
EUROAPI | Biotechnology | Director/Board Member | |
Sanofi-Aventis Deutschland GmbH
![]() Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Talix Therapeutics NV | Chairman | ||
Emergence Therapeutics AG
![]() Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Chairman | |
VEON LTD. | Wireless Telecommunications | Director/Board Member | |
Hoechst GmbH
![]() Hoechst GmbH Pharmaceuticals: MajorHealth Technology Part of Sanofi, Hoechst GmbH is a German company that manufactures and sells drugs. The company is based in Frankfurt, Germany. The CEO of the company is Fabrizio Guidi. | Pharmaceuticals: Major | Director/Board Member | |
Georgetown University | College/University | Graduate Degree | |
SANOFI | Pharmaceuticals: Major | General Counsel | |
BNP Paribas SA (London Branch)
![]() BNP Paribas SA (London Branch) Investment Banks/BrokersFinance BNP Paribas (London Branch) is the Great Britain-based brokerage division of BNP Paribas SA (EPA: BNP) in France. The firm is headquartered in London and was founded in 1986. BNP Paribas (London Branch) offers a wide range of products and services to corporate, institutional, commodities, market making and broking clients. | Investment Banks/Brokers | Analyst-Fixed Income | |
BliNK Biomedical SAS
![]() BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Biotechnology | Chief Executive Officer | |
CNH INDUSTRIAL N.V. | Trucks/Construction/Farm Machinery | Director/Board Member | |
Genesta SAS
![]() Genesta SAS Investment ManagersFinance Genesta SAS is an investment research firm headquartered in Paris, France. The firm was founded by Hervé Guyot in 2007 and is a subsidiary of In Extenso Finance & Transmission SAS. Genesta provides equity research to serve companies and entrepreneurs, with distribution to institutional investors and individuals. They have a team of analysts dedicated to the world of Small and Mid-Caps, positioned on the one hand in the Digital Technologies sectors (Internet Media, IT Services, Software, Video Games, etc.) and on the other in the Biotech/Medtech segments. | Investment Managers | Analyst-Equity | |
KPMG SA (Spain)
![]() KPMG SA (Spain) Miscellaneous Commercial ServicesCommercial Services Part of KPMG International Cooperative, KPMG SA (Spain) is a Spanish company that provides business support services. The company is based in Madrid, Spain. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Universite Toulouse 1 Capitole | College/University | Undergraduate Degree | |
Toulouse Business School - TBS EESC | College/University | Masters Business Admin | |
Stifel Europe Bank AG (France)
![]() Stifel Europe Bank AG (France) Investment Banks/BrokersFinance Stifel Europe Bank AG (France) (Stifel Europe Bank Paris Branch) is the French securities brokerage division of Germany-based Stifel Europe Bank AG. The firm was founded in 2012 and is ultimately owned by Stifel Financial Corp. (NYSE: SF) in the US. Headquartered in Paris, Stifel Europe Bank Paris Branch provides securities brokerage to institutional clients. | Investment Banks/Brokers | Analyst-Equity | |
B. Metzler seel. Sohn & Co. AG (Broker) | Investment Banks/Brokers | Analyst-Equity | |
Frankfurt School of Finance & Management | College/University | Undergraduate Degree | |
Instituto de Empresa SL | College/University | Graduate Degree | |
Université Libre de Bruxelles | College/University | Corporate Officer/Principal | |
Health Economics & Outcomes Research Ltd.
![]() Health Economics & Outcomes Research Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2011, Health Economics & Outcomes Research Ltd. is a British management consulting company that provides consulting services. The company is based in Cardiff, UK and is part of HEOR Holdings Ltd. | Miscellaneous Commercial Services | Director/Board Member | |
Lundbeck SAS
![]() Lundbeck SAS Pharmaceuticals: MajorHealth Technology Lundbeck SAS is a pharmaceutical laboratory, which focuses on neurology and psychiatry. The company was founded in 1992 and is headquartered in Paris La Defense, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Université Paris-Saclay | College/University | Doctorate Degree | |
Université de Limoges | College/University | Masters Business Admin | |
Colegio Universitario de Estudios Financieros | College/University | Undergraduate Degree | |
Altamar Private Equity SGIIC SA /Private Equity/
![]() Altamar Private Equity SGIIC SA /Private Equity/ Investment ManagersFinance Altamar Private Equity SGIIC SA (Altamar Private Equity) is a private equity arm of Altamar Capital Partners SL founded in 2004. The firm is headquartered in Spain with additional offices in New York and Santiago de Chile. | Investment Managers | Private Equity Investor | |
BioNet Pharma GmbH
![]() BioNet Pharma GmbH Miscellaneous Commercial ServicesCommercial Services BioNet Pharma GmbH engages in development of medical devices, pharmaceutical drugs and regenerative medical products. Its pipeline covers pre-clinical and clinical development programs in osteoarthritis, inflammatory joint disease, cartilage injury, and severe gingival inflammation. The company is headquartered in Martinsried, Germany. | Miscellaneous Commercial Services | Chief Executive Officer | |
Delta Alternative Management SAS
![]() Delta Alternative Management SAS Investment ManagersFinance Delta Alternative Management SAS (Delta AM) is a portfolio management firm headquartered in Paris, France. The firm was founded in 2008 by Frédéric Haym, Thibaut Sciard and Carlos Andrade. They are owned by Dôm Finance SAS (75%) and their founders (25%), which include 1% by employees. Delta AM offers investment strategies to finance small and medium-sized enterprises (SMEs) and intermediate-sized enterprises (ETIs) reserved for qualified investors. | Investment Managers | Analyst-Equity |
Statistiques
Internationale
France | 28 |
Allemagne | 7 |
Royaume-Uni | 5 |
Espagne | 5 |
Etats-Unis | 4 |
Sectorielle
Finance | 23 |
Consumer Services | 12 |
Health Technology | 10 |
Commercial Services | 5 |
Communications | 2 |
Opérationnelle
Analyst-Equity | 93 |
Director/Board Member | 39 |
Corporate Officer/Principal | 20 |
Independent Dir/Board Member | 12 |
Chairman | 11 |
Relations les plus connectées
- Bourse
- Insiders
- Arsène Guekam
- Connexions Sociétés